The findings of a recent study demonstrate only an association, not causality, with the researchers noting that another unknown factor may play a role.
To avoid significant fines and penalties, it is essential for pharmacies to be aware of and implement new regulatory changes adopted by the Drug Enforcement Agency.
The November 2023 ACC/AHA/ACCP/HRS release suggests early, aggressive rhythm control and provides parameters for pausing or stopping therapies, among other recommendations.